399 related articles for article (PubMed ID: 27068103)
21. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
Malyszko J; Malyszko JS; Mysliwiec M
Transplant Proc; 2009 Oct; 41(8):3056-9. PubMed ID: 19857675
[TBL] [Abstract][Full Text] [Related]
22. Blockade of Interleukin 6 by Rat Anti-mouse Interleukin 6 Receptor Antibody Promotes Fracture Healing.
Huang L; Liu S; Song T; Zhang W; Fan J; Liu Y
Biochemistry (Mosc); 2017 Oct; 82(10):1193-1199. PubMed ID: 29037140
[TBL] [Abstract][Full Text] [Related]
23. The dietary flavonoid myricetin regulates iron homeostasis by suppressing hepcidin expression.
Mu M; An P; Wu Q; Shen X; Shao D; Wang H; Zhang Y; Zhang S; Yao H; Min J; Wang F
J Nutr Biochem; 2016 Apr; 30():53-61. PubMed ID: 27012621
[TBL] [Abstract][Full Text] [Related]
24. Iron-deficiency anemia in Castleman disease: implication of the interleukin 6/hepcidin pathway.
Arlet JB; Hermine O; Darnige L; Ostland V; Westerman M; Badoual C; Pouchot J; Capron L
Pediatrics; 2010 Dec; 126(6):e1608-12. PubMed ID: 21041280
[TBL] [Abstract][Full Text] [Related]
25. Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice.
Tomiyama-Hanayama M; Rakugi H; Kohara M; Mima T; Adachi Y; Ohishi M; Katsuya T; Hoshida Y; Aozasa K; Ogihara T; Nishimoto N
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F679-84. PubMed ID: 19570877
[TBL] [Abstract][Full Text] [Related]
26. Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin.
Przybylowski P; Malyszko JS; Macdougall IC; Malyszko J
Transplant Proc; 2013; 45(1):387-90. PubMed ID: 23375326
[TBL] [Abstract][Full Text] [Related]
27. Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice.
Kobara M; Noda K; Kitamura M; Okamoto A; Shiraishi T; Toba H; Matsubara H; Nakata T
Cardiovasc Res; 2010 Aug; 87(3):424-30. PubMed ID: 20211866
[TBL] [Abstract][Full Text] [Related]
28. Effects of exposure to electromagnetic field from mobile phone on serum hepcidin and iron status in male albino rats.
El-Maleky NF; Ebrahim RH
Electromagn Biol Med; 2019; 38(1):66-73. PubMed ID: 30388901
[TBL] [Abstract][Full Text] [Related]
29. LC-MS/MS method for hepcidin-25 measurement in human and mouse serum: clinical and research implications in iron disorders.
Lefebvre T; Dessendier N; Houamel D; Ialy-Radio N; Kannengiesser C; Manceau H; Beaumont C; Nicolas G; Gouya L; Puy H; Karim Z
Clin Chem Lab Med; 2015 Sep; 53(10):1557-67. PubMed ID: 25781546
[TBL] [Abstract][Full Text] [Related]
30. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
[TBL] [Abstract][Full Text] [Related]
31. Inflammation neither increases hepatic hepcidin nor affects intestinal (59)Fe-absorption in two murine models of bowel inflammation, hemizygous TNF(ΔARE/+) and homozygous IL-10(-/-) mice.
Buffler M; Becker C; Windisch W; Schümann K
J Trace Elem Med Biol; 2015 Oct; 32():162-7. PubMed ID: 26302924
[TBL] [Abstract][Full Text] [Related]
32. IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice.
Mihara M; Takagi N; Takeda Y; Ohsugi Y
Clin Exp Immunol; 1998 Jun; 112(3):397-402. PubMed ID: 9649207
[TBL] [Abstract][Full Text] [Related]
33. Hepcidin and Anemia in Surgical Critical Care: A Prospective Cohort Study.
Cherry-Bukowiec JR; Engoren M; Wiktor A; Raghavendran K; Napolitano LM
Crit Care Med; 2018 Jun; 46(6):e567-e574. PubMed ID: 29517550
[TBL] [Abstract][Full Text] [Related]
34. Hepcidin-dependent and hepcidin-independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation.
Langdon JM; Yates SC; Femnou LK; McCranor BJ; Cheadle C; Xue QL; Vaulont S; Civin CI; Walston JD; Roy CN
Am J Hematol; 2014 May; 89(5):470-9. PubMed ID: 24415655
[TBL] [Abstract][Full Text] [Related]
35. Regulation of hepcidin through GDF-15 in cancer-related anemia.
Jiang F; Yu WJ; Wang XH; Tang YT; Guo L; Jiao XY
Clin Chim Acta; 2014 Jan; 428():14-9. PubMed ID: 24384540
[TBL] [Abstract][Full Text] [Related]
36. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.
Takagi N; Mihara M; Moriya Y; Nishimoto N; Yoshizaki K; Kishimoto T; Takeda Y; Ohsugi Y
Arthritis Rheum; 1998 Dec; 41(12):2117-21. PubMed ID: 9870868
[TBL] [Abstract][Full Text] [Related]
37. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation.
Jain M; Joharapurkar A; Patel V; Kshirsagar S; Sutariya B; Patel M; Patel H; Patel PR
Eur J Pharmacol; 2019 Jan; 843():113-120. PubMed ID: 30458168
[TBL] [Abstract][Full Text] [Related]
39. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.
Mecklenburg I; Reznik D; Fasler-Kan E; Drewe J; Beglinger C; Hruz P;
J Crohns Colitis; 2014 Nov; 8(11):1392-7. PubMed ID: 24825446
[TBL] [Abstract][Full Text] [Related]
40. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery.
Tussing-Humphreys LM; Nemeth E; Fantuzzi G; Freels S; Holterman AX; Galvani C; Ayloo S; Vitello J; Braunschweig C
Obesity (Silver Spring); 2010 Oct; 18(10):2010-6. PubMed ID: 20075851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
